Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study — Stella

Recruiting

Back to Huntington Disease trials

Trial locations(1 site)

United States

Sanguine Biosciences, Inc., Woburn, Massachusetts

Key details

Sponsor

Sanguine Biosciences

Collaborators

Hoffmann-La Roche

Enrollment target

~5 participants

Started

March 2023

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

25 Years – 65 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov